\contentsline {chapter}{\numberline {1}Introduction}{1}{chapter.1}
\contentsline {section}{\numberline {1.1}Cancer Research in the Post-Genomic Era}{1}{section.1.1}
\contentsline {subsection}{\numberline {1.1.1}Cancer as a Global Health Concern}{2}{subsection.1.1.1}
\contentsline {subsubsection}{\numberline {1.1.1.1}Genetics and Molecular Biology in Cancers}{3}{subsubsection.1.1.1.1}
\contentsline {subsection}{\numberline {1.1.2}The Human Genome Revolution}{5}{subsection.1.1.2}
\contentsline {subsubsection}{\numberline {1.1.2.1}The First Human Genome Sequence}{5}{subsubsection.1.1.2.1}
\contentsline {subsubsection}{\numberline {1.1.2.2}Expectations of Genomics}{6}{subsubsection.1.1.2.2}
\contentsline {subsection}{\numberline {1.1.3}Technologies to Enable Genetics Research}{6}{subsection.1.1.3}
\contentsline {subsubsection}{\numberline {1.1.3.1}DNA Sequencing and Genotyping Technologies}{6}{subsubsection.1.1.3.1}
\contentsline {subsubsection}{\numberline {1.1.3.2}Microarrays and Quantitative Technologies}{7}{subsubsection.1.1.3.2}
\contentsline {subsubsection}{\numberline {1.1.3.3}Massively Parallel ``Next Generation'' Sequencing}{8}{subsubsection.1.1.3.3}
\contentsline {subsubsubsection}{\numberline {1.1.3.3.1}Molecular Profiles with Genomics Technology}{10}{subsubsubsection.1.1.3.3.1}
\contentsline {subsubsubsection}{\numberline {1.1.3.3.2}Established Sequencing Technologies}{10}{subsubsubsection.1.1.3.3.2}
\contentsline {subsubsubsection}{\numberline {1.1.3.3.3}Emerging Sequencing Technologies}{11}{subsubsubsection.1.1.3.3.3}
\contentsline {subsubsection}{\numberline {1.1.3.4}Bioinformatics as Interdisciplinary Genomic Analysis}{13}{subsubsection.1.1.3.4}
\contentsline {subsubsection}{\numberline {1.1.3.5}Gene Expression Studies with Microarrays}{14}{subsubsection.1.1.3.5}
\contentsline {subsection}{\numberline {1.1.4}Follow-up Large-Scale Genomics Projects}{14}{subsection.1.1.4}
\contentsline {subsection}{\numberline {1.1.5}Cancer Genomes}{15}{subsection.1.1.5}
\contentsline {subsubsection}{\numberline {1.1.5.1}The Cancer Genome Atlas Project}{16}{subsubsection.1.1.5.1}
\contentsline {subsubsection}{\numberline {1.1.5.2}The International Cancer Genome Consortium}{16}{subsubsection.1.1.5.2}
\contentsline {subsubsubsection}{\numberline {1.1.5.2.1}Findings of the TCGA and ICGC Projects}{17}{subsubsubsection.1.1.5.2.1}
\contentsline {subsection}{\numberline {1.1.6}Genomic Cancer Medicine}{17}{subsection.1.1.6}
\contentsline {subsubsection}{\numberline {1.1.6.1}Cancer Genes and Driver Mutations}{17}{subsubsection.1.1.6.1}
\contentsline {subsubsubsection}{\numberline {1.1.6.1.1}Characterisation from Genomics Projects}{18}{subsubsubsection.1.1.6.1.1}
\contentsline {subsubsection}{\numberline {1.1.6.2}Personalised or Precision Cancer Medicine}{18}{subsubsection.1.1.6.2}
\contentsline {subsubsubsection}{\numberline {1.1.6.2.1}Molecular Diagnostics and Pan-Cancer Medicine}{19}{subsubsubsection.1.1.6.2.1}
\contentsline {subsubsection}{\numberline {1.1.6.3}Targeted Therapeutics and Pharmacogenomics}{19}{subsubsection.1.1.6.3}
\contentsline {subsubsubsection}{\numberline {1.1.6.3.1}Targeting Oncogenic Driver Mutations}{20}{subsubsubsection.1.1.6.3.1}
\contentsline {subsubsection}{\numberline {1.1.6.4}Systems and Network Biology}{20}{subsubsection.1.1.6.4}
\contentsline {subsubsubsection}{\numberline {1.1.6.4.1} Network Medicine, and Polypharmacology}{23}{subsubsubsection.1.1.6.4.1}
\contentsline {section}{\numberline {1.2}A Synthetic Lethal Approach to Cancer Medicine}{24}{section.1.2}
\contentsline {subsection}{\numberline {1.2.1}Synthetic Lethal Genetic Interactions}{24}{subsection.1.2.1}
\contentsline {subsection}{\numberline {1.2.2}Synthetic Lethal Concepts in Genetics}{25}{subsection.1.2.2}
\contentsline {subsection}{\numberline {1.2.3}Studies of Synthetic Lethality}{26}{subsection.1.2.3}
\contentsline {subsubsection}{\numberline {1.2.3.1}Synthetic Lethal Pathways and Networks}{27}{subsubsection.1.2.3.1}
\contentsline {subsubsubsection}{\numberline {1.2.3.1.1}Conservation and Evolution of Synthetic Lethality}{27}{subsubsubsection.1.2.3.1.1}
\contentsline {subsection}{\numberline {1.2.4}Synthetic Lethal Concepts in Cancer}{28}{subsection.1.2.4}
\contentsline {subsection}{\numberline {1.2.5}Clinical Impact of Synthetic Lethality in Cancer}{29}{subsection.1.2.5}
\contentsline {subsection}{\numberline {1.2.6}High{}-throughput Screening for Synthetic Lethality}{31}{subsection.1.2.6}
\contentsline {subsubsection}{\numberline {1.2.6.1}Examples of Synthetic Lethal Screens}{33}{subsubsection.1.2.6.1}
\contentsline {subsection}{\numberline {1.2.7}Computational Prediction of Synthetic Lethality}{36}{subsection.1.2.7}
\contentsline {section}{\numberline {1.3}E-cadherin as a Synthetic Lethal Target}{44}{section.1.3}
\contentsline {subsection}{\numberline {1.3.1}The \textit {CDH1} gene and it's Biological Functions}{45}{subsection.1.3.1}
\contentsline {subsubsection}{\numberline {1.3.1.1}Cytoskeleton}{45}{subsubsection.1.3.1.1}
\contentsline {subsubsection}{\numberline {1.3.1.2}Extracellular and Tumour Micro-Environment}{45}{subsubsection.1.3.1.2}
\contentsline {subsubsection}{\numberline {1.3.1.3}Cell-Cell Adhesion and Signalling}{46}{subsubsection.1.3.1.3}
\contentsline {subsection}{\numberline {1.3.2}\textit {CDH1} as a Tumour (and Invasion) Suppressor}{46}{subsection.1.3.2}
\contentsline {subsubsection}{\numberline {1.3.2.1}Breast Cancers and Invasion}{46}{subsubsection.1.3.2.1}
\contentsline {subsection}{\numberline {1.3.3}Hereditary Diffuse Gastric Cancer and Lobular Breast Cancer}{47}{subsection.1.3.3}
\contentsline {subsection}{\numberline {1.3.4}Somatic Mutations}{48}{subsection.1.3.4}
\contentsline {subsubsection}{\numberline {1.3.4.1}Mutation Rate}{48}{subsubsection.1.3.4.1}
\contentsline {subsubsection}{\numberline {1.3.4.2}Co-occuring Mutations}{49}{subsubsection.1.3.4.2}
\contentsline {subsection}{\numberline {1.3.5}Models of \textit {CDH1} loss in cell lines}{50}{subsection.1.3.5}
\contentsline {section}{\numberline {1.4}Summary and Research Direction of Thesis}{50}{section.1.4}
\contentsline {chapter}{\numberline {2}Methods, Techniques, and Resources}{52}{chapter.2}
\contentsline {section}{\numberline {2.1}Bioinformatics Resources to Enable Genomics Research}{52}{section.2.1}
\contentsline {subsection}{\numberline {2.1.1}Public Data and Software Packages}{52}{subsection.2.1.1}
\contentsline {subsubsection}{\numberline {2.1.1.1}Cancer Genome Atlas Data}{53}{subsubsection.2.1.1.1}
\contentsline {subsubsection}{\numberline {2.1.1.2}Reactome and Annotation Data}{54}{subsubsection.2.1.1.2}
\contentsline {section}{\numberline {2.2}Data Handling}{54}{section.2.2}
\contentsline {subsection}{\numberline {2.2.1}Normalisation (voom)}{54}{subsection.2.2.1}
\contentsline {subsection}{\numberline {2.2.2}Sample triage}{54}{subsection.2.2.2}
\contentsline {subsection}{\numberline {2.2.3}Pathway Metagenes and the Singular Value Decomposition}{56}{subsection.2.2.3}
\contentsline {subsubsection}{\numberline {2.2.3.1}Candidate Triage and Integration with Screen Data}{56}{subsubsection.2.2.3.1}
\contentsline {section}{\numberline {2.3}Techniques}{59}{section.2.3}
\contentsline {subsection}{\numberline {2.3.1}Statistical Procedures and Tests}{59}{subsection.2.3.1}
\contentsline {subsection}{\numberline {2.3.2}Gene Set Over-representation Analysis}{60}{subsection.2.3.2}
\contentsline {subsection}{\numberline {2.3.3}Clustering}{61}{subsection.2.3.3}
\contentsline {subsection}{\numberline {2.3.4}Heatmap}{61}{subsection.2.3.4}
\contentsline {subsection}{\numberline {2.3.5}Modeling and Simulations}{61}{subsection.2.3.5}
\contentsline {subsubsection}{\numberline {2.3.5.1}Reciever Operator Curves (Statistical Performance)}{62}{subsubsection.2.3.5.1}
\contentsline {subsection}{\numberline {2.3.6}Permutation and Resampling Analysis}{63}{subsection.2.3.6}
\contentsline {section}{\numberline {2.4}Pathway Structure Methods}{63}{section.2.4}
\contentsline {subsection}{\numberline {2.4.1}Network and Graph Analysis}{63}{subsection.2.4.1}
\contentsline {subsection}{\numberline {2.4.2}Sourcing Graph Structure Data}{64}{subsection.2.4.2}
\contentsline {subsection}{\numberline {2.4.3}Constructing Pathway Subgraphs}{65}{subsection.2.4.3}
\contentsline {subsection}{\numberline {2.4.4}Network Analysis Metrics}{65}{subsection.2.4.4}
\contentsline {section}{\numberline {2.5}Implementation}{66}{section.2.5}
\contentsline {subsection}{\numberline {2.5.1}Computational Resources and Linux Utilities}{66}{subsection.2.5.1}
\contentsline {subsection}{\numberline {2.5.2}R Language and Packages}{67}{subsection.2.5.2}
\contentsline {subsection}{\numberline {2.5.3}High Performance and Parallel Computing}{70}{subsection.2.5.3}
\contentsline {chapter}{\numberline {3}Methods Developed During Thesis}{71}{chapter.3}
\contentsline {section}{\numberline {3.1}A Synthetic Lethal Detection Methodology}{71}{section.3.1}
\contentsline {subsection}{\numberline {3.1.1}Supporting Data}{73}{subsection.3.1.1}
\contentsline {section}{\numberline {3.2}Simulations and Modelling Synthetic Lethality in Expression Data}{74}{section.3.2}
\contentsline {subsection}{\numberline {3.2.1}A Model of Synthetic Lethality}{74}{subsection.3.2.1}
\contentsline {subsection}{\numberline {3.2.2}Simulation Procedure}{78}{subsection.3.2.2}
\contentsline {section}{\numberline {3.3}Detecting Simulated Synthetic Lethal Partners}{80}{section.3.3}
\contentsline {subsection}{\numberline {3.3.1}Multivariate Normal Simulation of Synthetic lethality}{81}{subsection.3.3.1}
\contentsline {subsubsection}{\numberline {3.3.1.1}Simulation with Directional Testing}{81}{subsubsection.3.3.1.1}
\contentsline {subsubsection}{\numberline {3.3.1.2}Simulation with Query-Correlated Pathways}{81}{subsubsection.3.3.1.2}
\contentsline {subsubsection}{\numberline {3.3.1.3}Simulated Expression Heatmaps}{82}{subsubsection.3.3.1.3}
\contentsline {subsection}{\numberline {3.3.2}Replication Simulation Heatmap}{82}{subsection.3.3.2}
\contentsline {section}{\numberline {3.4}Graph Structure Methods}{82}{section.3.4}
\contentsline {subsection}{\numberline {3.4.1}Upstream and Downstream Gene Detection}{82}{subsection.3.4.1}
\contentsline {subsubsection}{\numberline {3.4.1.1}Permutation Analysis for Statisical Significance}{83}{subsubsection.3.4.1.1}
\contentsline {subsection}{\numberline {3.4.2}Simulating Gene Expression from Graph Structures}{83}{subsection.3.4.2}
\contentsline {section}{\numberline {3.5}Customised methods and R packages developed}{85}{section.3.5}
\contentsline {subsection}{\numberline {3.5.1}slipt}{85}{subsection.3.5.1}
\contentsline {subsection}{\numberline {3.5.2}plotting}{85}{subsection.3.5.2}
\contentsline {subsection}{\numberline {3.5.3}simulation from graph structures}{85}{subsection.3.5.3}
\contentsline {subsection}{\numberline {3.5.4}igraph methods}{85}{subsection.3.5.4}
\contentsline {chapter}{\numberline {4}Synthetic Lethal Analysis of Gene Expression Data}{88}{chapter.4}
\contentsline {section}{\numberline {4.1}Abstract}{88}{section.4.1}
\contentsline {section}{\numberline {4.2}Aims and Significance}{89}{section.4.2}
\contentsline {section}{\numberline {4.3}Background}{90}{section.4.3}
\contentsline {section}{\numberline {4.4}Background}{95}{section.4.4}
\contentsline {section}{\numberline {4.5}Sourcing TCGA data}{96}{section.4.5}
\contentsline {section}{\numberline {4.6}Quality checking}{96}{section.4.6}
\contentsline {section}{\numberline {4.7}Global Synthetic Lethality}{96}{section.4.7}
\contentsline {section}{\numberline {4.8}CDH1 Analysis with Subgroups}{97}{section.4.8}
\contentsline {section}{\numberline {4.9}Cell Line Analysis}{97}{section.4.9}
\contentsline {section}{\numberline {4.10}Mutation, Copy Number, and Methylation}{97}{section.4.10}
\contentsline {section}{\numberline {4.11}ANOVA of Expression Predictors}{98}{section.4.11}
\contentsline {section}{\numberline {4.12}Mutation Analysis, Pathway Expression, and Metagene Synthetic Lethality}{99}{section.4.12}
\contentsline {section}{\numberline {4.13}Data clean up, gene SL, and pathway SL}{100}{section.4.13}
\contentsline {section}{\numberline {4.14}Overview of Challenges}{101}{section.4.14}
\contentsline {section}{\numberline {4.15}Comparison of gene SL predictions and siRNA screen candidates}{102}{section.4.15}
\contentsline {section}{\numberline {4.16}Permutation or Re-Sampling of genes for pathway enrichment.}{103}{section.4.16}
\contentsline {section}{\numberline {4.17}Comparison of candidate SL Pathways}{104}{section.4.17}
\contentsline {section}{\numberline {4.18}Future Directions}{104}{section.4.18}
\contentsline {section}{\numberline {4.19}Hub Genes}{105}{section.4.19}
\contentsline {section}{\numberline {4.20}Metagene pathway expression}{105}{section.4.20}
\contentsline {section}{\numberline {4.21}Metagene synthetic lethality}{105}{section.4.21}
\contentsline {section}{\numberline {4.22}Replication in stomach cancer}{105}{section.4.22}
\contentsline {section}{\numberline {4.23}Important Results}{105}{section.4.23}
\contentsline {chapter}{\numberline {5}Pathway Structure of Synthetic Lethal Genes}{108}{chapter.5}
\contentsline {section}{\numberline {5.1}Abstract}{108}{section.5.1}
\contentsline {section}{\numberline {5.2}Background}{109}{section.5.2}
\contentsline {section}{\numberline {5.3}Reactome Network structure and Information Centrality as a measure of gene essentiality}{109}{section.5.3}
\contentsline {section}{\numberline {5.4}Synthetic lethal genes in synthetic lethal pathways}{110}{section.5.4}
\contentsline {section}{\numberline {5.5}Methods}{110}{section.5.5}
\contentsline {subsection}{\numberline {5.5.1}Sourcing graph structure data}{110}{subsection.5.5.1}
\contentsline {subsection}{\numberline {5.5.2}Constructing pathway subgraphs}{110}{subsection.5.5.2}
\contentsline {subsection}{\numberline {5.5.3}Centrality Measures}{110}{subsection.5.5.3}
\contentsline {subsection}{\numberline {5.5.4}upstream and downstream gene detection}{110}{subsection.5.5.4}
\contentsline {subsection}{\numberline {5.5.5}permutation analysis}{110}{subsection.5.5.5}
\contentsline {section}{\numberline {5.6}Centrality and connectivity of synthetic lethal genes}{110}{section.5.6}
\contentsline {section}{\numberline {5.7}Upstream or downstream synthetic lethal candidates}{110}{section.5.7}
\contentsline {section}{\numberline {5.8}Hierachical approach}{110}{section.5.8}
\contentsline {section}{\numberline {5.9}Discussion}{110}{section.5.9}
\contentsline {section}{\numberline {5.10}Conclusion}{110}{section.5.10}
\contentsline {chapter}{\numberline {6}Simulation and Modeling of Synthetic Lethal Pathways}{111}{chapter.6}
\contentsline {section}{\numberline {6.1}Abstract}{111}{section.6.1}
\contentsline {section}{\numberline {6.2}Background}{112}{section.6.2}
\contentsline {section}{\numberline {6.3}Simulations and Modelling Synthetic Lethality in Expression Data}{114}{section.6.3}
\contentsline {section}{\numberline {6.4}Developing a Synthetic Lethal detection methodology}{115}{section.6.4}
\contentsline {subsection}{\numberline {6.4.1}Testing Multivariate Normal Simulation of Synthetic lethality}{115}{subsection.6.4.1}
\contentsline {subsection}{\numberline {6.4.2}Receiver Operating Characteristic Curves}{116}{subsection.6.4.2}
\contentsline {subsection}{\numberline {6.4.3}Simulated Expression Heatmaps}{118}{subsection.6.4.3}
\contentsline {subsection}{\numberline {6.4.4}Replication Simulation Heatmap}{119}{subsection.6.4.4}
\contentsline {section}{\numberline {6.5}Simulation of synthetic lethality in graph structures}{122}{section.6.5}
\contentsline {subsection}{\numberline {6.5.1}Developing a multivariate normal expression from graph structures}{122}{subsection.6.5.1}
\contentsline {subsection}{\numberline {6.5.2}Simulations over simple graph structures}{122}{subsection.6.5.2}
\contentsline {subsubsection}{\numberline {6.5.2.1}Performance}{122}{subsubsection.6.5.2.1}
\contentsline {subsubsection}{\numberline {6.5.2.2}Synthetic lethality across graph stuctures}{122}{subsubsection.6.5.2.2}
\contentsline {subsubsection}{\numberline {6.5.2.3}Performance with inhibition links}{122}{subsubsection.6.5.2.3}
\contentsline {subsubsection}{\numberline {6.5.2.4}Performance with 20,000 genes}{122}{subsubsection.6.5.2.4}
\contentsline {subsection}{\numberline {6.5.3}Simulations over pathway-based graphs}{122}{subsection.6.5.3}
\contentsline {subsection}{\numberline {6.5.4}Comparing methods}{122}{subsection.6.5.4}
\contentsline {subsubsection}{\numberline {6.5.4.1}SLIPT and Chi-Squared}{122}{subsubsection.6.5.4.1}
\contentsline {subsubsubsection}{\numberline {6.5.4.1.1}Correlated query genes}{122}{subsubsubsection.6.5.4.1.1}
\contentsline {subsubsection}{\numberline {6.5.4.2}Correlation}{122}{subsubsection.6.5.4.2}
\contentsline {subsubsection}{\numberline {6.5.4.3}Linear models}{122}{subsubsection.6.5.4.3}
\contentsline {subsection}{\numberline {6.5.5}Developing a linear model predictor of synthetic lethality}{122}{subsection.6.5.5}
\contentsline {subsubsection}{\numberline {6.5.5.1}Linear models}{122}{subsubsection.6.5.5.1}
\contentsline {subsubsection}{\numberline {6.5.5.2}Polynomial models}{122}{subsubsection.6.5.5.2}
\contentsline {subsubsection}{\numberline {6.5.5.3}Conditioning}{122}{subsubsection.6.5.5.3}
\contentsline {subsubsection}{\numberline {6.5.5.4}SLIPTv2}{122}{subsubsection.6.5.5.4}
\contentsline {section}{\numberline {6.6}Significance}{122}{section.6.6}
\contentsline {section}{\numberline {6.7}Future Directions}{124}{section.6.7}
\contentsline {section}{\numberline {6.8}Conclusion}{125}{section.6.8}
\contentsline {chapter}{\numberline {7}Discussion}{126}{chapter.7}
\contentsline {chapter}{\numberline {8}Conclusion}{127}{chapter.8}
\contentsline {chapter}{\hbox to\@tempdima {\hfil }References}{128}{chapter.8}
\contentsline {chapter}{\numberline {A}Software Used for Thesis}{152}{appendix.A}
